CHOSA has carried out a directed issue of SEK 5,58 million to fund KOL-initiated DRP validation studies and to increase business development activities
The board of CHOSA Oncology AB (publ) ("CHOSA" or the "Company") has today, 3. April 2024, performed a directed issue of 6 070 233 shares at a price of SEK 0,92 per share. The subscription price per share has been set under market conform conditions based upon Volume Weighted Average Price (VWAP) over a period of 10 trading days up to and including 2. April 2024, which was the last trading day for the share before the Board of Director’s decision on the Directed Issue. This will increase the number of shares from 64 873 913 to 70 944 146. In anticipation of the Directed Issue, the board